A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
Am J Nephrol
; 46(5): 364-370, 2017.
Article
in En
| MEDLINE
| ID: mdl-29084409
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biosimilar Pharmaceuticals
/
Epoetin Alfa
/
Hematinics
/
Anemia
/
Kidney Failure, Chronic
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Am J Nephrol
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland